STOCK TITAN

Beam Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Beam Therapeutics (Nasdaq: BEAM) will have CEO John Evans presenting at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 11:40 a.m. ET. Investors can access a live webcast on the company’s website, which will also be archived for 60 days. Beam Therapeutics specializes in precision genetic medicines using base editing technology, allowing precise genomic modifications without DNA breaks. Their innovative approach aims to deliver effective therapeutic solutions for serious diseases.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2021 at 11:40 a.m. ET.

The live webcast will be available in the investor section of the company's website at www.beamtx.com. The webcast will be archived for 60 days following the presentation.

About Beam Therapeutics

Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company developing precision genetic medicines through the use of base editing. Beam’s proprietary base editors create precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This enables a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. For more information, visit www.beamtx.com.

Contacts:

Investors:
Chelcie Lister
THRUST Strategic Communications
chelcie@thrustsc.com

Media:
Dan Budwick
1AB
dan@1abmedia.com


FAQ

What date is Beam Therapeutics presenting at the J.P. Morgan Healthcare Conference?

Beam Therapeutics will present on January 12, 2021.

What time is the Beam Therapeutics presentation scheduled at the J.P. Morgan Healthcare Conference?

The presentation is scheduled for 11:40 a.m. ET.

Where can I watch the Beam Therapeutics presentation live?

The presentation can be watched live on Beam Therapeutics' investor section of their website.

How long will the Beam Therapeutics presentation be available for replay?

The webcast will be archived for 60 days after the presentation.

What technology does Beam Therapeutics use for genetic medicine?

Beam Therapeutics uses base editing technology for precision genetic medicines.

Beam Therapeutics Inc.

NASDAQ:BEAM

BEAM Rankings

BEAM Latest News

BEAM Stock Data

2.12B
81.62M
1.42%
93.11%
14.87%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE